According to the new market research "Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy,
Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps,
Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) -
Global Forecast to 2021" published by MarketsandMarkets
Don’t
miss out on business opportunities in Lung
Cancer Surgery Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=222
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=222
The
objectives of this study are as follows:
- · To define, describe, and forecast the global lung cancer surgery market by device, surgery, and region
- · To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
- · To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- · To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- · To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
- · To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- · To track and analyze competitive developments such as product launches, agreements, expansions, acquisitions, and other developments in the global lung cancer surgery market
Browse and in-depth TOC on “Lung Cancer Surgery
Market "
85 – Tables
44 – Figures
135 – Page
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html
85 – Tables
44 – Figures
135 – Page
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html
Based on procedure, the market is segmented into
thoracotomy and minimally invasive surgeries. The thoracotomy segment further
sub segmented into lobectomy, segmentectomy, sleeve resection, and
pneumonectomy. The minimally invasive surgeries segment is expected to grow at
the highest CAGR during the forecast period due to increasing awareness about
early detection of lung cancer and advantages of MIS over conventional
surgeries.
Based on region, the market is segmented into
North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North
America is expected to account for the largest share of the market. Growth in
this market is mainly driven by the increasing geriatric population,
availability of reimbursement for lung cancer surgeries, increasing number of
lung cancer awareness programs, and technological advancements in cancer
treatment.
Market
Players
Key players in the lung cancer surgery market
include Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus
Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex
Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany),
Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).
Comments
Post a Comment